| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thermogenesis | 42 | 2024 | 475 | 11.210 |
Why?
|
| Adipose Tissue, Brown | 59 | 2022 | 764 | 9.040 |
Why?
|
| Adipocytes | 81 | 2024 | 1194 | 8.860 |
Why?
|
| Transcription Factors | 180 | 2023 | 12128 | 5.980 |
Why?
|
| Adipose Tissue | 100 | 2023 | 3312 | 5.600 |
Why?
|
| Trans-Activators | 58 | 2013 | 2856 | 5.290 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 66 | 2013 | 857 | 5.160 |
Why?
|
| Energy Metabolism | 52 | 2024 | 2882 | 3.690 |
Why?
|
| Creatine | 9 | 2024 | 427 | 3.500 |
Why?
|
| Fibronectins | 14 | 2024 | 723 | 3.350 |
Why?
|
| PPAR gamma | 20 | 2020 | 484 | 3.240 |
Why?
|
| Thiazolidinediones | 27 | 2020 | 461 | 2.640 |
Why?
|
| Mitochondria | 36 | 2024 | 3624 | 2.450 |
Why?
|
| DNA-Binding Proteins | 69 | 2016 | 9606 | 2.320 |
Why?
|
| Gene Expression Regulation | 96 | 2022 | 11903 | 2.280 |
Why?
|
| Physical Conditioning, Animal | 14 | 2021 | 365 | 2.250 |
Why?
|
| Muscle, Skeletal | 44 | 2024 | 4948 | 2.200 |
Why?
|
| Obesity | 70 | 2024 | 12947 | 2.090 |
Why?
|
| Mice | 254 | 2024 | 81525 | 1.920 |
Why?
|
| Animals | 320 | 2024 | 168459 | 1.780 |
Why?
|
| Cachexia | 6 | 2019 | 202 | 1.760 |
Why?
|
| Transcription, Genetic | 53 | 2015 | 7594 | 1.730 |
Why?
|
| Adipose Tissue, White | 11 | 2020 | 365 | 1.710 |
Why?
|
| Cell Differentiation | 94 | 2020 | 11528 | 1.630 |
Why?
|
| Gluconeogenesis | 11 | 2011 | 185 | 1.580 |
Why?
|
| Mitochondrial Proteins | 24 | 2021 | 976 | 1.560 |
Why?
|
| Heat-Shock Proteins | 10 | 2013 | 795 | 1.360 |
Why?
|
| Adipocytes, Brown | 7 | 2018 | 150 | 1.360 |
Why?
|
| Ion Channels | 21 | 2016 | 1040 | 1.320 |
Why?
|
| Insulin Resistance | 34 | 2021 | 3963 | 1.310 |
Why?
|
| Muscle Fibers, Skeletal | 7 | 2014 | 542 | 1.270 |
Why?
|
| Amidohydrolases | 3 | 2020 | 159 | 1.250 |
Why?
|
| Mice, Knockout | 50 | 2024 | 14414 | 1.230 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 24 | 2005 | 286 | 1.190 |
Why?
|
| Glucose | 25 | 2021 | 4346 | 1.180 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 4 | 2014 | 615 | 1.180 |
Why?
|
| Reactive Oxygen Species | 8 | 2020 | 2141 | 1.180 |
Why?
|
| 3T3 Cells | 37 | 2014 | 1085 | 1.150 |
Why?
|
| Sympathetic Nervous System | 2 | 2020 | 518 | 1.090 |
Why?
|
| Transcriptional Activation | 25 | 2014 | 1756 | 1.050 |
Why?
|
| Cysteine | 3 | 2021 | 891 | 1.010 |
Why?
|
| Cyclin-Dependent Kinase 5 | 4 | 2014 | 112 | 1.000 |
Why?
|
| Signal Transduction | 29 | 2024 | 23445 | 0.990 |
Why?
|
| Nerve Tissue Proteins | 19 | 2020 | 4414 | 0.980 |
Why?
|
| Cold Temperature | 10 | 2021 | 785 | 0.980 |
Why?
|
| Carcinoma, Lewis Lung | 2 | 2015 | 108 | 0.960 |
Why?
|
| Cells, Cultured | 56 | 2020 | 18965 | 0.950 |
Why?
|
| Homeostasis | 21 | 2021 | 3323 | 0.940 |
Why?
|
| Serine Endopeptidases | 23 | 1996 | 1022 | 0.930 |
Why?
|
| Mice, Inbred C57BL | 54 | 2024 | 22169 | 0.920 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 7 | 2024 | 687 | 0.920 |
Why?
|
| Liver | 26 | 2021 | 7529 | 0.920 |
Why?
|
| Adipogenesis | 5 | 2020 | 368 | 0.910 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 6 | 2010 | 102 | 0.880 |
Why?
|
| Cell Respiration | 9 | 2017 | 201 | 0.840 |
Why?
|
| Saposins | 1 | 2023 | 26 | 0.840 |
Why?
|
| Tumor Necrosis Factor-alpha | 17 | 2011 | 4352 | 0.840 |
Why?
|
| Mice, Transgenic | 41 | 2020 | 9539 | 0.830 |
Why?
|
| Insulin | 36 | 2019 | 6596 | 0.830 |
Why?
|
| Mitochondria, Muscle | 9 | 2023 | 172 | 0.820 |
Why?
|
| Complement Factor D | 24 | 2019 | 66 | 0.820 |
Why?
|
| MAP Kinase Signaling System | 7 | 2024 | 1486 | 0.810 |
Why?
|
| Alkaline Phosphatase | 2 | 2024 | 864 | 0.780 |
Why?
|
| Ligands | 26 | 2019 | 3272 | 0.780 |
Why?
|
| Gene Expression Regulation, Developmental | 13 | 2013 | 3612 | 0.780 |
Why?
|
| Carrier Proteins | 25 | 2006 | 4936 | 0.780 |
Why?
|
| Cell Line | 56 | 2024 | 15601 | 0.770 |
Why?
|
| Extracellular Fluid | 1 | 2023 | 165 | 0.770 |
Why?
|
| Osteocytes | 2 | 2024 | 192 | 0.770 |
Why?
|
| RNA, Messenger | 60 | 2014 | 12795 | 0.760 |
Why?
|
| Phosphocreatine | 2 | 2022 | 261 | 0.760 |
Why?
|
| Thiazoles | 21 | 2010 | 1517 | 0.750 |
Why?
|
| Nuclear Proteins | 32 | 2004 | 5796 | 0.740 |
Why?
|
| Cell Communication | 2 | 2023 | 1657 | 0.690 |
Why?
|
| Neoplasm Proteins | 15 | 2008 | 3617 | 0.670 |
Why?
|
| Integrin alphaV | 1 | 2018 | 54 | 0.640 |
Why?
|
| Oleic Acids | 1 | 2018 | 74 | 0.610 |
Why?
|
| Muscle Proteins | 5 | 2016 | 1154 | 0.600 |
Why?
|
| Amidinotransferases | 1 | 2017 | 11 | 0.590 |
Why?
|
| 5' Untranslated Regions | 1 | 2019 | 256 | 0.590 |
Why?
|
| Muscle Fibers, Slow-Twitch | 3 | 2010 | 52 | 0.590 |
Why?
|
| Gene Expression | 23 | 2021 | 7581 | 0.580 |
Why?
|
| Receptors, Adrenergic | 1 | 2017 | 155 | 0.580 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2017 | 57 | 0.570 |
Why?
|
| Receptors, Estrogen | 9 | 2013 | 2208 | 0.570 |
Why?
|
| Muscle Fibers, Fast-Twitch | 2 | 2007 | 70 | 0.570 |
Why?
|
| Selenium | 1 | 2020 | 417 | 0.560 |
Why?
|
| Acclimatization | 1 | 2017 | 113 | 0.560 |
Why?
|
| Diabetes Mellitus, Experimental | 9 | 2010 | 1119 | 0.550 |
Why?
|
| Insulin-Secreting Cells | 3 | 2019 | 901 | 0.550 |
Why?
|
| Osteolysis | 1 | 2018 | 275 | 0.550 |
Why?
|
| Fibroblast Growth Factors | 3 | 2012 | 867 | 0.550 |
Why?
|
| Fats | 2 | 2016 | 99 | 0.540 |
Why?
|
| Electron Transport | 1 | 2017 | 210 | 0.540 |
Why?
|
| Parathyroid Hormone-Related Protein | 2 | 2015 | 327 | 0.540 |
Why?
|
| Phosphorylation | 22 | 2020 | 8320 | 0.540 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 6 | 2021 | 1651 | 0.530 |
Why?
|
| Open Reading Frames | 2 | 2019 | 815 | 0.530 |
Why?
|
| Adaptation, Physiological | 6 | 2013 | 1301 | 0.520 |
Why?
|
| Transfection | 28 | 2007 | 5774 | 0.510 |
Why?
|
| Heme | 2 | 2009 | 313 | 0.510 |
Why?
|
| Genes, fos | 10 | 1998 | 176 | 0.510 |
Why?
|
| TRPV Cation Channels | 2 | 2018 | 244 | 0.500 |
Why?
|
| Glutamine | 1 | 2018 | 577 | 0.490 |
Why?
|
| Base Sequence | 46 | 2009 | 12441 | 0.490 |
Why?
|
| Subcutaneous Fat | 3 | 2019 | 393 | 0.490 |
Why?
|
| Bone Remodeling | 1 | 2018 | 581 | 0.490 |
Why?
|
| Enhancer Elements, Genetic | 11 | 2004 | 1363 | 0.490 |
Why?
|
| Promoter Regions, Genetic | 31 | 2008 | 5789 | 0.480 |
Why?
|
| Gene Expression Profiling | 14 | 2014 | 9420 | 0.470 |
Why?
|
| Molecular Sequence Data | 41 | 2015 | 17635 | 0.470 |
Why?
|
| Calcium-Binding Proteins | 2 | 2019 | 1069 | 0.470 |
Why?
|
| Receptors, Retinoic Acid | 8 | 1999 | 224 | 0.470 |
Why?
|
| Fibroblasts | 13 | 2009 | 4141 | 0.460 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2015 | 305 | 0.460 |
Why?
|
| Diabetes Mellitus, Type 2 | 13 | 2023 | 12148 | 0.450 |
Why?
|
| Cell Division | 14 | 2007 | 4465 | 0.450 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2018 | 602 | 0.450 |
Why?
|
| Glucose Tolerance Test | 9 | 2016 | 1178 | 0.450 |
Why?
|
| Interleukin-17 | 1 | 2020 | 912 | 0.450 |
Why?
|
| Science | 2 | 2010 | 239 | 0.440 |
Why?
|
| Fasting | 8 | 2013 | 1603 | 0.440 |
Why?
|
| Oxidative Phosphorylation | 5 | 2017 | 496 | 0.440 |
Why?
|
| Histone Demethylases | 1 | 2016 | 320 | 0.440 |
Why?
|
| Lipid Metabolism | 9 | 2021 | 1902 | 0.430 |
Why?
|
| Oxidation-Reduction | 8 | 2018 | 2231 | 0.430 |
Why?
|
| Complement C3a | 3 | 2019 | 66 | 0.430 |
Why?
|
| Organ Specificity | 14 | 2020 | 1967 | 0.420 |
Why?
|
| Hepatocytes | 6 | 2013 | 1233 | 0.420 |
Why?
|
| Metabolic Diseases | 4 | 2015 | 683 | 0.410 |
Why?
|
| Oxygen Consumption | 10 | 2019 | 1866 | 0.410 |
Why?
|
| Male | 96 | 2024 | 360804 | 0.410 |
Why?
|
| Carboplatin | 3 | 2018 | 794 | 0.410 |
Why?
|
| Glycerides | 4 | 1993 | 67 | 0.400 |
Why?
|
| Resistance Training | 3 | 2016 | 193 | 0.400 |
Why?
|
| Stem Cells | 10 | 2020 | 3522 | 0.400 |
Why?
|
| Exercise | 9 | 2024 | 5890 | 0.400 |
Why?
|
| Fatty Acids | 13 | 2019 | 1808 | 0.400 |
Why?
|
| Receptors, Tumor Necrosis Factor | 6 | 1997 | 585 | 0.400 |
Why?
|
| Amino Acid Sequence | 24 | 2016 | 13446 | 0.400 |
Why?
|
| Receptor, Insulin | 7 | 2001 | 835 | 0.400 |
Why?
|
| Neurodegenerative Diseases | 5 | 2007 | 1087 | 0.390 |
Why?
|
| Forkhead Transcription Factors | 7 | 2011 | 1616 | 0.390 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 14 | 2005 | 135 | 0.380 |
Why?
|
| Nerve Growth Factors | 1 | 2014 | 564 | 0.370 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2011 | 29 | 0.370 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2004 | 1246 | 0.370 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2011 | 203 | 0.370 |
Why?
|
| Cell Biology | 1 | 2011 | 90 | 0.360 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2011 | 183 | 0.360 |
Why?
|
| Mice, Obese | 8 | 2016 | 420 | 0.360 |
Why?
|
| Dietary Fats | 8 | 2012 | 1995 | 0.360 |
Why?
|
| Phosphoproteins | 10 | 2008 | 2448 | 0.360 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 3 | 2006 | 126 | 0.350 |
Why?
|
| Humans | 141 | 2024 | 761504 | 0.350 |
Why?
|
| Rats | 30 | 2018 | 23742 | 0.350 |
Why?
|
| Hormones | 7 | 2021 | 869 | 0.350 |
Why?
|
| Glucocorticoids | 4 | 2016 | 2161 | 0.350 |
Why?
|
| Proto-Oncogene Proteins c-jun | 11 | 1996 | 286 | 0.350 |
Why?
|
| Hypoglycemic Agents | 15 | 2011 | 3085 | 0.350 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2009 | 33 | 0.340 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 926 | 0.340 |
Why?
|
| Muscles | 8 | 2023 | 1576 | 0.340 |
Why?
|
| Myoblasts | 3 | 2013 | 231 | 0.340 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 809 | 0.340 |
Why?
|
| Cloning, Molecular | 13 | 2000 | 4174 | 0.330 |
Why?
|
| Diabetes Mellitus | 11 | 2014 | 5840 | 0.330 |
Why?
|
| Physiology | 1 | 2010 | 111 | 0.330 |
Why?
|
| Chromans | 8 | 2003 | 117 | 0.330 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2015 | 1741 | 0.330 |
Why?
|
| Pericytes | 1 | 2012 | 293 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-fos | 15 | 1998 | 586 | 0.320 |
Why?
|
| Adipokines | 3 | 2023 | 310 | 0.320 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 1188 | 0.320 |
Why?
|
| Parathyroid Hormone | 1 | 2015 | 1803 | 0.320 |
Why?
|
| Unfolded Protein Response | 1 | 2011 | 234 | 0.320 |
Why?
|
| Multienzyme Complexes | 3 | 2007 | 666 | 0.310 |
Why?
|
| Myosin Heavy Chains | 3 | 2014 | 405 | 0.310 |
Why?
|
| Proto-Oncogenes | 5 | 1990 | 321 | 0.310 |
Why?
|
| Membrane Proteins | 9 | 2019 | 7856 | 0.310 |
Why?
|
| HEK293 Cells | 6 | 2019 | 4278 | 0.300 |
Why?
|
| Cyclic AMP | 11 | 2021 | 1463 | 0.300 |
Why?
|
| Protein Binding | 14 | 2020 | 9351 | 0.300 |
Why?
|
| Phosphoserine | 4 | 2014 | 203 | 0.300 |
Why?
|
| DNA Damage | 1 | 2018 | 2446 | 0.300 |
Why?
|
| Microtubules | 6 | 2008 | 1074 | 0.290 |
Why?
|
| Tubulin Modulators | 1 | 2008 | 107 | 0.290 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2008 | 169 | 0.290 |
Why?
|
| Muscular Atrophy | 3 | 2024 | 334 | 0.290 |
Why?
|
| Glycoproteins | 6 | 2000 | 2203 | 0.290 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 5 | 2003 | 489 | 0.280 |
Why?
|
| Cell Lineage | 4 | 2015 | 2555 | 0.280 |
Why?
|
| Temperature | 2 | 2013 | 2226 | 0.280 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 1250 | 0.280 |
Why?
|
| Colonic Neoplasms | 4 | 2005 | 2538 | 0.270 |
Why?
|
| Proto-Oncogene Proteins | 10 | 2022 | 4511 | 0.270 |
Why?
|
| Body Temperature Regulation | 4 | 2000 | 292 | 0.270 |
Why?
|
| Adipocytes, White | 4 | 2014 | 91 | 0.270 |
Why?
|
| Triglycerides | 7 | 2009 | 2461 | 0.260 |
Why?
|
| Blood Proteins | 3 | 2020 | 1173 | 0.260 |
Why?
|
| Gene Expression Regulation, Enzymologic | 7 | 2001 | 1171 | 0.260 |
Why?
|
| Recombinant Proteins | 16 | 2013 | 6534 | 0.260 |
Why?
|
| Neurons | 6 | 2019 | 9463 | 0.260 |
Why?
|
| Glucose-6-Phosphatase | 3 | 2016 | 72 | 0.260 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 4 | 2013 | 502 | 0.260 |
Why?
|
| Hippocampus | 4 | 2018 | 3766 | 0.260 |
Why?
|
| Porphyrias | 1 | 2005 | 57 | 0.250 |
Why?
|
| Leigh Disease | 1 | 2006 | 89 | 0.250 |
Why?
|
| Enzyme Activation | 5 | 2016 | 3597 | 0.250 |
Why?
|
| COS Cells | 5 | 2011 | 1130 | 0.250 |
Why?
|
| Helix-Loop-Helix Motifs | 4 | 1998 | 96 | 0.250 |
Why?
|
| Cardiac Output, Low | 1 | 2006 | 191 | 0.250 |
Why?
|
| Blotting, Northern | 10 | 1997 | 1545 | 0.250 |
Why?
|
| Interferon Regulatory Factors | 2 | 2018 | 261 | 0.240 |
Why?
|
| Hypertrophy | 3 | 2024 | 561 | 0.240 |
Why?
|
| Protein Isoforms | 7 | 2022 | 1699 | 0.240 |
Why?
|
| Protein Structure, Tertiary | 6 | 2011 | 3792 | 0.240 |
Why?
|
| Cell Line, Transformed | 6 | 2006 | 867 | 0.240 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2024 | 29 | 0.240 |
Why?
|
| Myostatin | 2 | 2018 | 129 | 0.240 |
Why?
|
| Oxidative Stress | 4 | 2013 | 3113 | 0.240 |
Why?
|
| Endopeptidases | 6 | 1987 | 774 | 0.240 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 1136 | 0.240 |
Why?
|
| Binding Sites | 14 | 2007 | 6055 | 0.230 |
Why?
|
| Neuromuscular Junction | 1 | 2007 | 405 | 0.230 |
Why?
|
| Genes, Regulator | 5 | 2008 | 373 | 0.230 |
Why?
|
| Hyperkinesis | 1 | 2004 | 89 | 0.230 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2007 | 267 | 0.230 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2020 | 1934 | 0.230 |
Why?
|
| Protons | 4 | 2019 | 1116 | 0.230 |
Why?
|
| Muscle Cells | 3 | 2012 | 195 | 0.230 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 4 | 2001 | 40 | 0.220 |
Why?
|
| Antineoplastic Agents | 6 | 2018 | 13639 | 0.220 |
Why?
|
| T-Lymphocytes | 3 | 2020 | 10194 | 0.220 |
Why?
|
| Interleukin-15 | 1 | 2024 | 185 | 0.220 |
Why?
|
| Culture Media, Conditioned | 3 | 2014 | 522 | 0.220 |
Why?
|
| Blood Glucose | 9 | 2016 | 6391 | 0.220 |
Why?
|
| Membrane Transport Proteins | 2 | 2019 | 1035 | 0.220 |
Why?
|
| Inflammation | 9 | 2021 | 10773 | 0.220 |
Why?
|
| Growth Substances | 5 | 1997 | 768 | 0.220 |
Why?
|
| Lipoproteins | 2 | 2020 | 881 | 0.220 |
Why?
|
| Exercise Test | 2 | 2016 | 2127 | 0.220 |
Why?
|
| GA-Binding Protein Transcription Factor | 4 | 2007 | 43 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 9 | 2016 | 6216 | 0.210 |
Why?
|
| Retinoid X Receptors | 8 | 1999 | 91 | 0.210 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2016 | 14 | 0.210 |
Why?
|
| Fatty Acid-Binding Proteins | 12 | 1996 | 296 | 0.210 |
Why?
|
| Angiogenesis Inducing Agents | 4 | 1993 | 278 | 0.210 |
Why?
|
| Transcription Factor AP-1 | 4 | 1997 | 321 | 0.210 |
Why?
|
| Glycerolphosphate Dehydrogenase | 7 | 1987 | 37 | 0.200 |
Why?
|
| Cell Separation | 3 | 2017 | 1720 | 0.200 |
Why?
|
| Amino Acids | 3 | 2020 | 1718 | 0.200 |
Why?
|
| STAT3 Transcription Factor | 2 | 2020 | 871 | 0.200 |
Why?
|
| Genes, APC | 1 | 2002 | 145 | 0.200 |
Why?
|
| Proteins | 7 | 2005 | 6032 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 9 | 2016 | 6075 | 0.200 |
Why?
|
| Cytoskeletal Proteins | 2 | 2005 | 1342 | 0.200 |
Why?
|
| Lipoma | 2 | 1995 | 293 | 0.190 |
Why?
|
| Models, Biological | 10 | 2010 | 9469 | 0.190 |
Why?
|
| Heart | 2 | 2015 | 4404 | 0.190 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2012 | 416 | 0.190 |
Why?
|
| RNA, Small Interfering | 7 | 2013 | 3429 | 0.190 |
Why?
|
| Myelin P2 Protein | 4 | 1996 | 20 | 0.190 |
Why?
|
| DNA | 15 | 1996 | 7212 | 0.190 |
Why?
|
| Fatty Liver | 3 | 2021 | 790 | 0.190 |
Why?
|
| Creatine Kinase, BB Form | 1 | 2021 | 7 | 0.190 |
Why?
|
| Muscle Development | 3 | 2008 | 259 | 0.190 |
Why?
|
| Complement System Proteins | 2 | 1996 | 736 | 0.190 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2002 | 130 | 0.190 |
Why?
|
| Protein Conformation | 5 | 2013 | 3968 | 0.190 |
Why?
|
| Hyperlipidemias | 2 | 2005 | 771 | 0.190 |
Why?
|
| Mice, Nude | 4 | 2018 | 3615 | 0.190 |
Why?
|
| Endothelial Growth Factors | 2 | 1995 | 673 | 0.190 |
Why?
|
| Growth Differentiation Factor 3 | 1 | 2020 | 11 | 0.180 |
Why?
|
| Atrophy | 2 | 2016 | 1633 | 0.180 |
Why?
|
| Adenosine Triphosphate | 6 | 2019 | 1989 | 0.180 |
Why?
|
| Myogenic Regulatory Factors | 4 | 2003 | 103 | 0.180 |
Why?
|
| Microvascular Angina | 1 | 2000 | 14 | 0.180 |
Why?
|
| 3T3-L1 Cells | 4 | 2011 | 209 | 0.180 |
Why?
|
| Microbodies | 2 | 1997 | 36 | 0.180 |
Why?
|
| Nuclear Respiratory Factors | 4 | 2001 | 18 | 0.180 |
Why?
|
| GTP-Binding Proteins | 3 | 1995 | 951 | 0.180 |
Why?
|
| Hydrolysis | 2 | 2021 | 664 | 0.180 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 16981 | 0.180 |
Why?
|
| Neovascularization, Physiologic | 1 | 2008 | 1349 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2016 | 3492 | 0.180 |
Why?
|
| Lymphokines | 2 | 1995 | 927 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 3 | 2014 | 1612 | 0.180 |
Why?
|
| Neprilysin | 1 | 2023 | 478 | 0.180 |
Why?
|
| Bone Resorption | 2 | 2024 | 723 | 0.180 |
Why?
|
| ADP-Ribosylation Factors | 4 | 1995 | 133 | 0.180 |
Why?
|
| Isoenzymes | 4 | 2014 | 1687 | 0.180 |
Why?
|
| Islets of Langerhans | 2 | 2003 | 1341 | 0.170 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2020 | 120 | 0.170 |
Why?
|
| Muscle Strength | 1 | 2024 | 624 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2019 | 47 | 0.170 |
Why?
|
| Mitochondrial ADP, ATP Translocases | 1 | 2019 | 11 | 0.170 |
Why?
|
| Corpus Striatum | 2 | 2022 | 1235 | 0.170 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2001 | 436 | 0.170 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2019 | 71 | 0.170 |
Why?
|
| Tuna | 1 | 2019 | 18 | 0.170 |
Why?
|
| Computational Biology | 1 | 2011 | 3518 | 0.170 |
Why?
|
| Genetic Vectors | 9 | 2013 | 3395 | 0.170 |
Why?
|
| Epoxy Compounds | 1 | 2000 | 137 | 0.170 |
Why?
|
| Kininogens | 1 | 2019 | 15 | 0.170 |
Why?
|
| Female | 49 | 2024 | 392644 | 0.170 |
Why?
|
| Oxygen | 5 | 2011 | 4227 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 9 | 2005 | 6132 | 0.160 |
Why?
|
| Amino Acid Motifs | 2 | 2018 | 931 | 0.160 |
Why?
|
| Diptera | 1 | 2019 | 50 | 0.160 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2021 | 695 | 0.160 |
Why?
|
| Osteoblasts | 2 | 2020 | 1143 | 0.160 |
Why?
|
| Ischemia | 1 | 2008 | 1882 | 0.160 |
Why?
|
| Macrophages | 3 | 2014 | 5769 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2012 | 3548 | 0.160 |
Why?
|
| Body Temperature | 3 | 2018 | 781 | 0.160 |
Why?
|
| Kinetics | 13 | 2013 | 6374 | 0.160 |
Why?
|
| Gastrointestinal Tract | 1 | 2005 | 833 | 0.160 |
Why?
|
| Adenosine Diphosphate | 2 | 2019 | 422 | 0.160 |
Why?
|
| Adenoviridae | 5 | 2013 | 1084 | 0.150 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2015 | 1541 | 0.150 |
Why?
|
| Myocytes, Cardiac | 3 | 2015 | 1668 | 0.150 |
Why?
|
| Biological Transport | 2 | 2019 | 2091 | 0.150 |
Why?
|
| Rats, Zucker | 5 | 2003 | 131 | 0.150 |
Why?
|
| Cytochromes c | 3 | 2007 | 173 | 0.150 |
Why?
|
| Insulin Receptor Substrate Proteins | 5 | 1999 | 557 | 0.150 |
Why?
|
| Neurites | 2 | 2019 | 391 | 0.150 |
Why?
|
| Liposarcoma | 2 | 1999 | 289 | 0.150 |
Why?
|
| Genes, jun | 2 | 1996 | 69 | 0.150 |
Why?
|
| Basal Metabolism | 2 | 2017 | 161 | 0.150 |
Why?
|
| 5-Aminolevulinate Synthetase | 2 | 2009 | 64 | 0.150 |
Why?
|
| Repressor Proteins | 3 | 2004 | 2986 | 0.140 |
Why?
|
| Tubulin | 6 | 1983 | 693 | 0.140 |
Why?
|
| Neoplasms | 4 | 2023 | 22170 | 0.140 |
Why?
|
| Myocardium | 3 | 2010 | 4726 | 0.140 |
Why?
|
| Quadriceps Muscle | 1 | 2018 | 156 | 0.140 |
Why?
|
| Models, Molecular | 4 | 2011 | 5439 | 0.140 |
Why?
|
| Mutation | 20 | 2019 | 30052 | 0.140 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2016 | 29 | 0.140 |
Why?
|
| Transgenes | 5 | 2010 | 1010 | 0.140 |
Why?
|
| RNA Splicing | 2 | 2000 | 918 | 0.140 |
Why?
|
| Immunoprecipitation | 1 | 2019 | 878 | 0.140 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2011 | 855 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 10 | 2003 | 3734 | 0.140 |
Why?
|
| Mentors | 1 | 2002 | 661 | 0.140 |
Why?
|
| Osteoclasts | 1 | 2020 | 711 | 0.140 |
Why?
|
| Retinoids | 1 | 1997 | 99 | 0.130 |
Why?
|
| Norepinephrine | 2 | 2016 | 897 | 0.130 |
Why?
|
| Osteogenesis | 3 | 2020 | 1273 | 0.130 |
Why?
|
| Crosses, Genetic | 3 | 2009 | 749 | 0.130 |
Why?
|
| Cytokines | 5 | 2011 | 7396 | 0.130 |
Why?
|
| Genes, Reporter | 6 | 2007 | 1529 | 0.130 |
Why?
|
| Hypothalamus | 3 | 2001 | 999 | 0.130 |
Why?
|
| Genes, Lethal | 2 | 1993 | 223 | 0.130 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2023 | 3080 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 629 | 0.130 |
Why?
|
| Arteriosclerosis | 1 | 2000 | 1055 | 0.130 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 1996 | 82 | 0.130 |
Why?
|
| Leptin | 7 | 2003 | 1597 | 0.130 |
Why?
|
| Antigens, CD | 2 | 1997 | 4003 | 0.130 |
Why?
|
| Genes, abl | 1 | 1995 | 69 | 0.130 |
Why?
|
| Cell Nucleus | 8 | 2008 | 2909 | 0.130 |
Why?
|
| alpha-Synuclein | 1 | 2022 | 750 | 0.130 |
Why?
|
| Protein Biosynthesis | 5 | 2008 | 2113 | 0.130 |
Why?
|
| Gene Deletion | 4 | 2021 | 2665 | 0.130 |
Why?
|
| Drosophila | 1 | 2023 | 1495 | 0.130 |
Why?
|
| Genes | 3 | 1989 | 1823 | 0.130 |
Why?
|
| Electrophysiological Phenomena | 1 | 2017 | 307 | 0.130 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1995 | 68 | 0.130 |
Why?
|
| Disease Models, Animal | 10 | 2022 | 18252 | 0.120 |
Why?
|
| Lung Neoplasms | 3 | 2018 | 13380 | 0.120 |
Why?
|
| Immunoblotting | 2 | 2016 | 1646 | 0.120 |
Why?
|
| Mass Spectrometry | 2 | 2020 | 2192 | 0.120 |
Why?
|
| Drug Synergism | 3 | 2008 | 1755 | 0.120 |
Why?
|
| Zebrafish | 3 | 2019 | 3007 | 0.120 |
Why?
|
| Muscle Contraction | 1 | 2010 | 1201 | 0.120 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2014 | 92 | 0.120 |
Why?
|
| Patch-Clamp Techniques | 1 | 2017 | 927 | 0.120 |
Why?
|
| Cell Transformation, Viral | 2 | 1995 | 526 | 0.120 |
Why?
|
| Sulfhydryl Compounds | 1 | 2016 | 301 | 0.120 |
Why?
|
| Collagen Type III | 1 | 2014 | 91 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2019 | 1974 | 0.120 |
Why?
|
| Hyperparathyroidism | 1 | 2015 | 337 | 0.120 |
Why?
|
| Acid Phosphatase | 1 | 2014 | 139 | 0.120 |
Why?
|
| Aminoisobutyric Acids | 1 | 2014 | 39 | 0.110 |
Why?
|
| Glucose Transporter Type 4 | 2 | 2007 | 240 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2016 | 491 | 0.110 |
Why?
|
| Drosophila Proteins | 1 | 2023 | 1699 | 0.110 |
Why?
|
| Glycolysis | 4 | 2023 | 835 | 0.110 |
Why?
|
| Isotope Labeling | 1 | 2015 | 392 | 0.110 |
Why?
|
| Glucose Clamp Technique | 3 | 2007 | 263 | 0.110 |
Why?
|
| Peptide Fragments | 4 | 2016 | 5112 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 6 | 1999 | 1058 | 0.110 |
Why?
|
| Energy Intake | 2 | 2001 | 2134 | 0.110 |
Why?
|
| Deuterium Exchange Measurement | 1 | 2013 | 31 | 0.110 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2007 | 598 | 0.110 |
Why?
|
| Thermodynamics | 1 | 2015 | 595 | 0.110 |
Why?
|
| Methylation | 1 | 2016 | 1084 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 484 | 0.110 |
Why?
|
| Diphtheria Toxin | 2 | 1996 | 253 | 0.110 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2013 | 56 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2023 | 2803 | 0.110 |
Why?
|
| History, 21st Century | 2 | 2024 | 1567 | 0.110 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 1134 | 0.110 |
Why?
|
| Receptors, Cell Surface | 3 | 1999 | 2822 | 0.110 |
Why?
|
| DNA Primers | 6 | 2004 | 2819 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 2 | 2012 | 2065 | 0.100 |
Why?
|
| Diglycerides | 1 | 1993 | 177 | 0.100 |
Why?
|
| Proteome | 1 | 2022 | 1862 | 0.100 |
Why?
|
| Phenotype | 6 | 2021 | 16591 | 0.100 |
Why?
|
| Cognition | 2 | 2021 | 6990 | 0.100 |
Why?
|
| Down-Regulation | 4 | 2023 | 2919 | 0.100 |
Why?
|
| Multiprotein Complexes | 2 | 2009 | 1118 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2014 | 8547 | 0.100 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 266 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 1996 | 2825 | 0.100 |
Why?
|
| Rats, Wistar | 4 | 2005 | 1848 | 0.100 |
Why?
|
| Neurogenesis | 1 | 2018 | 863 | 0.100 |
Why?
|
| Interleukin-13 | 1 | 2014 | 392 | 0.100 |
Why?
|
| Integrases | 2 | 2009 | 516 | 0.100 |
Why?
|
| Second Messenger Systems | 1 | 1992 | 202 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 789 | 0.100 |
Why?
|
| Receptors, Thyroid Hormone | 2 | 2002 | 199 | 0.100 |
Why?
|
| Sirtuin 1 | 2 | 2010 | 246 | 0.100 |
Why?
|
| Activin Receptors, Type II | 1 | 2012 | 123 | 0.100 |
Why?
|
| Amino Acid Substitution | 3 | 2008 | 1738 | 0.100 |
Why?
|
| Phylogeny | 1 | 2019 | 2811 | 0.100 |
Why?
|
| Fetal Death | 1 | 1993 | 435 | 0.090 |
Why?
|
| Mitogens | 3 | 1996 | 230 | 0.090 |
Why?
|
| Cell Cycle | 3 | 1997 | 2932 | 0.090 |
Why?
|
| Cholesterol | 5 | 2005 | 2904 | 0.090 |
Why?
|
| History, 20th Century | 2 | 2024 | 2767 | 0.090 |
Why?
|
| Aorta | 3 | 2006 | 2042 | 0.090 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 2 | 2012 | 61 | 0.090 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 476 | 0.090 |
Why?
|
| Organ Size | 3 | 2014 | 2254 | 0.090 |
Why?
|
| Transcription Factor CHOP | 1 | 2011 | 68 | 0.090 |
Why?
|
| Immunohistochemistry | 6 | 2015 | 11076 | 0.090 |
Why?
|
| Macromolecular Substances | 5 | 2004 | 1434 | 0.090 |
Why?
|
| Aging | 4 | 2015 | 8708 | 0.090 |
Why?
|
| Calcium | 4 | 2017 | 5722 | 0.090 |
Why?
|
| X-Rays | 1 | 2011 | 307 | 0.090 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2011 | 277 | 0.090 |
Why?
|
| NIH 3T3 Cells | 2 | 2010 | 670 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 3 | 2018 | 1961 | 0.090 |
Why?
|
| Cell Survival | 4 | 2010 | 5791 | 0.090 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2010 | 42 | 0.090 |
Why?
|
| Nephrectomy | 1 | 2015 | 937 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 4575 | 0.090 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1992 | 393 | 0.090 |
Why?
|
| Molecular Conformation | 1 | 2011 | 544 | 0.090 |
Why?
|
| Nucleoproteins | 2 | 1988 | 113 | 0.090 |
Why?
|
| Biophysics | 1 | 2011 | 380 | 0.090 |
Why?
|
| Interleukin-4 | 1 | 2014 | 1149 | 0.090 |
Why?
|
| Oxidants | 2 | 2010 | 169 | 0.090 |
Why?
|
| Cell Proliferation | 4 | 2015 | 10445 | 0.090 |
Why?
|
| Cell Size | 1 | 2012 | 624 | 0.090 |
Why?
|
| Adiponectin | 2 | 2011 | 1113 | 0.090 |
Why?
|
| Scattering, Radiation | 1 | 2011 | 490 | 0.090 |
Why?
|
| Complement Activating Enzymes | 1 | 1989 | 22 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2003 | 318 | 0.080 |
Why?
|
| Bone and Bones | 1 | 2020 | 2568 | 0.080 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 8599 | 0.080 |
Why?
|
| Cricetinae | 7 | 1998 | 2423 | 0.080 |
Why?
|
| Intra-Abdominal Fat | 1 | 2014 | 613 | 0.080 |
Why?
|
| Smad Proteins | 1 | 2010 | 156 | 0.080 |
Why?
|
| Vasodilation | 1 | 1993 | 962 | 0.080 |
Why?
|
| Models, Cardiovascular | 1 | 2015 | 981 | 0.080 |
Why?
|
| Melanocytes | 1 | 2013 | 509 | 0.080 |
Why?
|
| Molecular Biology | 1 | 2013 | 576 | 0.080 |
Why?
|
| Histone Acetyltransferases | 2 | 2003 | 336 | 0.080 |
Why?
|
| PPAR delta | 1 | 2009 | 40 | 0.080 |
Why?
|
| Muscular Diseases | 2 | 2018 | 553 | 0.080 |
Why?
|
| Body Mass Index | 5 | 2021 | 12953 | 0.080 |
Why?
|
| Tissue Distribution | 2 | 2010 | 2265 | 0.080 |
Why?
|
| Cytochrome-c Oxidase Deficiency | 1 | 2008 | 14 | 0.080 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2003 | 1841 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 1 | 1995 | 940 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2000 | 2748 | 0.080 |
Why?
|
| Mediator Complex Subunit 1 | 3 | 2003 | 30 | 0.080 |
Why?
|
| Motor Neurons | 2 | 2012 | 870 | 0.080 |
Why?
|
| Microcirculation | 1 | 1993 | 1273 | 0.080 |
Why?
|
| Myogenic Regulatory Factor 5 | 1 | 2008 | 26 | 0.080 |
Why?
|
| Monocytes | 1 | 1998 | 2570 | 0.080 |
Why?
|
| Stearoyl-CoA Desaturase | 2 | 1999 | 85 | 0.080 |
Why?
|
| Adiposity | 2 | 2022 | 1878 | 0.080 |
Why?
|
| Cycloheximide | 3 | 2013 | 343 | 0.080 |
Why?
|
| Vasodilator Agents | 1 | 1993 | 973 | 0.080 |
Why?
|
| Superoxide Dismutase | 2 | 2012 | 594 | 0.080 |
Why?
|
| Mitochondrial Myopathies | 1 | 2008 | 50 | 0.080 |
Why?
|
| Plasma | 1 | 2012 | 586 | 0.080 |
Why?
|
| Flow Cytometry | 3 | 2012 | 5869 | 0.080 |
Why?
|
| Presynaptic Terminals | 1 | 2010 | 302 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2015 | 1023 | 0.080 |
Why?
|
| Body Composition | 3 | 2021 | 2426 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2022 | 2877 | 0.080 |
Why?
|
| Fungal Proteins | 1 | 1992 | 910 | 0.080 |
Why?
|
| Keratinocytes | 3 | 1997 | 790 | 0.080 |
Why?
|
| Recombination, Genetic | 3 | 2003 | 1519 | 0.080 |
Why?
|
| Anaerobic Threshold | 1 | 2008 | 51 | 0.080 |
Why?
|
| Heterozygote | 3 | 2009 | 2787 | 0.070 |
Why?
|
| Ketones | 1 | 2009 | 184 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2003 | 814 | 0.070 |
Why?
|
| Corticosterone | 1 | 1989 | 305 | 0.070 |
Why?
|
| RNA-Binding Proteins | 3 | 2006 | 1897 | 0.070 |
Why?
|
| Multigene Family | 3 | 2005 | 1076 | 0.070 |
Why?
|
| Drug Design | 1 | 2013 | 1048 | 0.070 |
Why?
|
| DNA, Single-Stranded | 1 | 1990 | 355 | 0.070 |
Why?
|
| Retinal Vessels | 1 | 1993 | 852 | 0.070 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2007 | 20 | 0.070 |
Why?
|
| Choristoma | 1 | 2009 | 206 | 0.070 |
Why?
|
| Phosphothreonine | 1 | 2007 | 62 | 0.070 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2001 | 618 | 0.070 |
Why?
|
| Co-Repressor Proteins | 1 | 2008 | 190 | 0.070 |
Why?
|
| Microscopy, Electron | 2 | 2018 | 2561 | 0.070 |
Why?
|
| Lipids | 4 | 2009 | 3341 | 0.070 |
Why?
|
| Complement Pathway, Alternative | 3 | 1993 | 113 | 0.070 |
Why?
|
| Brain | 6 | 2023 | 27112 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2005 | 1693 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 1 | 2010 | 906 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 2917 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1993 | 1493 | 0.070 |
Why?
|
| Reference Values | 5 | 1997 | 4920 | 0.070 |
Why?
|
| Mice, Inbred mdx | 1 | 2007 | 88 | 0.070 |
Why?
|
| RNA Interference | 4 | 2013 | 2831 | 0.070 |
Why?
|
| Epinephrine | 2 | 2006 | 792 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2008 | 193 | 0.070 |
Why?
|
| Hydrogen Peroxide | 2 | 2010 | 730 | 0.070 |
Why?
|
| Receptors, Adrenergic, beta-3 | 2 | 2017 | 62 | 0.070 |
Why?
|
| Thinness | 3 | 2014 | 490 | 0.070 |
Why?
|
| Genes, ras | 3 | 2008 | 654 | 0.070 |
Why?
|
| Cell Cycle Proteins | 2 | 2001 | 3448 | 0.070 |
Why?
|
| Weight Gain | 3 | 2014 | 2348 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2007 | 293 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2011 | 10766 | 0.070 |
Why?
|
| Gene Targeting | 4 | 2001 | 838 | 0.070 |
Why?
|
| Blotting, Western | 4 | 2012 | 5035 | 0.070 |
Why?
|
| Body Weight | 5 | 2009 | 4618 | 0.070 |
Why?
|
| Cyclic CMP | 1 | 2006 | 6 | 0.070 |
Why?
|
| Tyrosine | 3 | 1996 | 1440 | 0.070 |
Why?
|
| Genes, Mitochondrial | 1 | 2006 | 59 | 0.070 |
Why?
|
| CREB-Binding Protein | 1 | 2006 | 148 | 0.070 |
Why?
|
| Apolipoproteins C | 1 | 2006 | 59 | 0.070 |
Why?
|
| Catalase | 1 | 2006 | 218 | 0.070 |
Why?
|
| Mice, Inbred Strains | 4 | 2008 | 1762 | 0.070 |
Why?
|
| Mice, Mutant Strains | 4 | 2014 | 1749 | 0.070 |
Why?
|
| Reference Standards | 1 | 2010 | 1003 | 0.070 |
Why?
|
| Receptors, Cholinergic | 1 | 2007 | 244 | 0.070 |
Why?
|
| Mice, Inbred C3H | 1 | 2007 | 915 | 0.070 |
Why?
|
| Mitochondria, Liver | 1 | 2006 | 190 | 0.070 |
Why?
|
| Extracellular Matrix | 2 | 2024 | 1726 | 0.070 |
Why?
|
| Histones | 1 | 2016 | 2580 | 0.060 |
Why?
|
| Alleles | 4 | 2020 | 6863 | 0.060 |
Why?
|
| Apolipoproteins A | 1 | 2006 | 95 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2005 | 4124 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 3 | 1990 | 2645 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 1996 | 779 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 1997 | 256 | 0.060 |
Why?
|
| Iodide Peroxidase | 1 | 2007 | 294 | 0.060 |
Why?
|
| Societies, Scientific | 1 | 2006 | 222 | 0.060 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 656 | 0.060 |
Why?
|
| Glucagon | 2 | 2005 | 532 | 0.060 |
Why?
|
| Nitriles | 1 | 2010 | 971 | 0.060 |
Why?
|
| Glutathione Peroxidase | 1 | 2006 | 258 | 0.060 |
Why?
|
| Response Elements | 3 | 2001 | 309 | 0.060 |
Why?
|
| Protein Kinases | 1 | 1992 | 1608 | 0.060 |
Why?
|
| Models, Animal | 1 | 2012 | 2112 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1994 | 2425 | 0.060 |
Why?
|
| Endothelium | 3 | 1986 | 765 | 0.060 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 4 | 1998 | 221 | 0.060 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2000 | 353 | 0.060 |
Why?
|
| Sodium Glutamate | 3 | 1993 | 23 | 0.060 |
Why?
|
| Complement Factor B | 2 | 1996 | 57 | 0.060 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2005 | 63 | 0.060 |
Why?
|
| Actins | 4 | 1992 | 2050 | 0.060 |
Why?
|
| Exons | 4 | 2003 | 2391 | 0.060 |
Why?
|
| Sarcopenia | 1 | 2009 | 372 | 0.060 |
Why?
|
| Plasmids | 4 | 2005 | 2269 | 0.060 |
Why?
|
| Serine | 2 | 2000 | 830 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2011 | 4740 | 0.060 |
Why?
|
| Diabetic Retinopathy | 1 | 1993 | 1274 | 0.060 |
Why?
|
| Appetite Regulation | 1 | 2004 | 84 | 0.060 |
Why?
|
| Genetic Markers | 1 | 2010 | 2601 | 0.060 |
Why?
|
| Flavonoids | 2 | 1998 | 445 | 0.060 |
Why?
|
| Basal Ganglia Diseases | 1 | 2004 | 145 | 0.060 |
Why?
|
| Apoptosis | 2 | 2018 | 9486 | 0.060 |
Why?
|
| Rats, Mutant Strains | 1 | 2003 | 60 | 0.060 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2004 | 73 | 0.060 |
Why?
|
| Interleukin-6 | 2 | 2018 | 3208 | 0.060 |
Why?
|
| Sciatic Nerve | 1 | 1987 | 617 | 0.060 |
Why?
|
| Sweden | 1 | 2006 | 1379 | 0.060 |
Why?
|
| Structure-Activity Relationship | 3 | 1995 | 3076 | 0.060 |
Why?
|
| RNA | 4 | 1997 | 2726 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2006 | 540 | 0.050 |
Why?
|
| Cattle | 4 | 1999 | 3849 | 0.050 |
Why?
|
| E1A-Associated p300 Protein | 2 | 2003 | 123 | 0.050 |
Why?
|
| Peptides | 1 | 2015 | 4358 | 0.050 |
Why?
|
| Models, Genetic | 3 | 2004 | 3442 | 0.050 |
Why?
|
| HeLa Cells | 6 | 2009 | 3093 | 0.050 |
Why?
|
| Physical Endurance | 2 | 2016 | 366 | 0.050 |
Why?
|
| Glucokinase | 1 | 2003 | 102 | 0.050 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2002 | 10 | 0.050 |
Why?
|
| Azoxymethane | 1 | 2002 | 35 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2003 | 73 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 1263 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 1334 | 0.050 |
Why?
|
| Mitochondrial Diseases | 1 | 2006 | 343 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2006 | 3778 | 0.050 |
Why?
|
| Cross-Over Studies | 2 | 2021 | 2078 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2006 | 1096 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 1998 | 1141 | 0.050 |
Why?
|
| Substrate Cycling | 1 | 2022 | 7 | 0.050 |
Why?
|
| Epithelium | 2 | 2005 | 1603 | 0.050 |
Why?
|
| Myoglobin | 1 | 2002 | 159 | 0.050 |
Why?
|
| Calcineurin | 1 | 2003 | 229 | 0.050 |
Why?
|
| Citric Acid Cycle | 1 | 2023 | 231 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 1997 | 790 | 0.050 |
Why?
|
| Endothelium, Vascular | 2 | 1995 | 4431 | 0.050 |
Why?
|
| Restriction Mapping | 3 | 1995 | 851 | 0.050 |
Why?
|
| Sirtuins | 1 | 2005 | 320 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 1995 | 748 | 0.050 |
Why?
|
| Muscle Fatigue | 1 | 2002 | 95 | 0.050 |
Why?
|
| Dexamethasone | 3 | 2000 | 1948 | 0.050 |
Why?
|
| Locomotion | 1 | 2024 | 388 | 0.050 |
Why?
|
| Peptide Initiation Factors | 1 | 2001 | 55 | 0.050 |
Why?
|
| Premenopause | 2 | 1997 | 1039 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2003 | 231 | 0.050 |
Why?
|
| Regional Blood Flow | 2 | 2016 | 1496 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2872 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 1667 | 0.050 |
Why?
|
| Isoproterenol | 3 | 1997 | 395 | 0.050 |
Why?
|
| PPAR alpha | 2 | 2014 | 175 | 0.050 |
Why?
|
| Dopamine beta-Hydroxylase | 2 | 1998 | 74 | 0.050 |
Why?
|
| Heparin | 2 | 1986 | 1634 | 0.050 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2012 | 1469 | 0.050 |
Why?
|
| Butyric Acid | 2 | 1993 | 51 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 1999 | 1791 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 1998 | 6346 | 0.050 |
Why?
|
| Simian virus 40 | 3 | 1992 | 291 | 0.050 |
Why?
|
| Enzymes | 2 | 1998 | 257 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2013 | 1320 | 0.040 |
Why?
|
| Enzyme Inhibitors | 4 | 2004 | 3712 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2021 | 2865 | 0.040 |
Why?
|
| Epididymis | 2 | 2017 | 228 | 0.040 |
Why?
|
| Creatine Kinase | 1 | 2002 | 685 | 0.040 |
Why?
|
| Blotting, Southern | 2 | 1992 | 777 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 837 | 0.040 |
Why?
|
| Carcinogens | 1 | 2002 | 452 | 0.040 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2000 | 100 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 2645 | 0.040 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 1999 | 42 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2004 | 633 | 0.040 |
Why?
|
| Angiopoietins | 1 | 2000 | 85 | 0.040 |
Why?
|
| Time Factors | 8 | 2005 | 39967 | 0.040 |
Why?
|
| Butyrates | 2 | 1993 | 169 | 0.040 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 1998 | 370 | 0.040 |
Why?
|
| DNA Probes | 2 | 2001 | 541 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2003 | 1090 | 0.040 |
Why?
|
| Biology | 1 | 2022 | 290 | 0.040 |
Why?
|
| Gene Silencing | 2 | 2005 | 1509 | 0.040 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 1999 | 21 | 0.040 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 1999 | 15 | 0.040 |
Why?
|
| Arachidonic Acids | 1 | 2020 | 294 | 0.040 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 1999 | 23 | 0.040 |
Why?
|
| Molecular Weight | 4 | 1989 | 2186 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2024 | 699 | 0.040 |
Why?
|
| Prostaglandin D2 | 2 | 1999 | 108 | 0.040 |
Why?
|
| Lipogenesis | 1 | 2021 | 214 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2001 | 305 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 3702 | 0.040 |
Why?
|
| DNA, Complementary | 3 | 1999 | 1991 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 2 | 1998 | 345 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2001 | 2898 | 0.040 |
Why?
|
| Feedback | 1 | 2003 | 791 | 0.040 |
Why?
|
| Neuropeptide Y | 2 | 1998 | 192 | 0.040 |
Why?
|
| Coenzymes | 1 | 2019 | 102 | 0.040 |
Why?
|
| Azo Compounds | 1 | 1999 | 117 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1997 | 817 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2008 | 2571 | 0.040 |
Why?
|
| Cell Dedifferentiation | 1 | 2019 | 122 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3816 | 0.040 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2000 | 214 | 0.040 |
Why?
|
| Adult | 13 | 2021 | 221177 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2003 | 733 | 0.040 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2000 | 363 | 0.040 |
Why?
|
| Thermosensing | 1 | 2018 | 55 | 0.040 |
Why?
|
| Leukotriene B4 | 1 | 1999 | 280 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2020 | 368 | 0.040 |
Why?
|
| Ion Transport | 1 | 2019 | 319 | 0.040 |
Why?
|
| Yeasts | 1 | 1999 | 279 | 0.040 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2003 | 740 | 0.040 |
Why?
|
| Radioimmunoassay | 2 | 1996 | 862 | 0.040 |
Why?
|
| src Homology Domains | 1 | 1999 | 361 | 0.040 |
Why?
|
| Troponin I | 1 | 2002 | 651 | 0.040 |
Why?
|
| Acyltransferases | 2 | 2005 | 305 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2000 | 488 | 0.040 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1997 | 138 | 0.040 |
Why?
|
| Transcription Factor DP1 | 1 | 1997 | 136 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 2 | 2023 | 3839 | 0.040 |
Why?
|
| Young Adult | 4 | 2021 | 59243 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2000 | 551 | 0.040 |
Why?
|
| Glycerol-3-Phosphate O-Acyltransferase | 1 | 1997 | 9 | 0.040 |
Why?
|
| Behavior, Animal | 3 | 2021 | 1878 | 0.040 |
Why?
|
| Purine Nucleotides | 1 | 2017 | 27 | 0.040 |
Why?
|
| beta Catenin | 1 | 2002 | 1040 | 0.040 |
Why?
|
| Complement C3 | 2 | 1996 | 435 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2002 | 1736 | 0.040 |
Why?
|
| Skin | 2 | 2009 | 4484 | 0.040 |
Why?
|
| Inguinal Canal | 1 | 2017 | 71 | 0.040 |
Why?
|
| Carboxypeptidase H | 1 | 1996 | 9 | 0.040 |
Why?
|
| Immobilization | 1 | 1998 | 229 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 1997 | 52 | 0.040 |
Why?
|
| Agouti Signaling Protein | 1 | 1996 | 23 | 0.040 |
Why?
|
| Carbazoles | 1 | 2018 | 220 | 0.030 |
Why?
|
| In Situ Hybridization | 3 | 2010 | 1900 | 0.030 |
Why?
|
| Serum Albumin | 1 | 2020 | 672 | 0.030 |
Why?
|
| Guanosine Triphosphate | 1 | 1977 | 316 | 0.030 |
Why?
|
| E2F Transcription Factors | 1 | 1997 | 269 | 0.030 |
Why?
|
| Chimera | 3 | 1999 | 453 | 0.030 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2000 | 323 | 0.030 |
Why?
|
| Catecholamines | 1 | 1998 | 386 | 0.030 |
Why?
|
| Glycine | 1 | 2020 | 663 | 0.030 |
Why?
|
| Kindling, Neurologic | 1 | 1996 | 24 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2000 | 902 | 0.030 |
Why?
|
| Arginine | 1 | 2000 | 934 | 0.030 |
Why?
|
| Carboxypeptidases | 1 | 1996 | 154 | 0.030 |
Why?
|
| Regression Analysis | 2 | 1997 | 6343 | 0.030 |
Why?
|
| Abelson murine leukemia virus | 1 | 1995 | 41 | 0.030 |
Why?
|
| Tretinoin | 1 | 1999 | 519 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1996 | 242 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 1995 | 5821 | 0.030 |
Why?
|
| Genetic Variation | 2 | 2005 | 6567 | 0.030 |
Why?
|
| Integrins | 1 | 2020 | 834 | 0.030 |
Why?
|
| Lipoprotein Lipase | 1 | 1996 | 133 | 0.030 |
Why?
|
| Action Potentials | 1 | 2003 | 1834 | 0.030 |
Why?
|
| Oncogenes | 2 | 1994 | 1222 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1997 | 329 | 0.030 |
Why?
|
| Career Choice | 1 | 2002 | 756 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2008 | 5305 | 0.030 |
Why?
|
| NAD | 2 | 2013 | 614 | 0.030 |
Why?
|
| Astrocytes | 1 | 2023 | 1346 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 1886 | 0.030 |
Why?
|
| Protein Sorting Signals | 1 | 1996 | 279 | 0.030 |
Why?
|
| Carboxy-Lyases | 1 | 1975 | 85 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 1827 | 0.030 |
Why?
|
| Aspergillus | 1 | 1975 | 93 | 0.030 |
Why?
|
| Cell Enlargement | 1 | 2015 | 60 | 0.030 |
Why?
|
| Receptors, Leptin | 1 | 1996 | 350 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2023 | 3162 | 0.030 |
Why?
|
| Food | 1 | 2000 | 774 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1998 | 641 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 1996 | 386 | 0.030 |
Why?
|
| Ceramides | 1 | 1996 | 201 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 1997 | 344 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2003 | 21012 | 0.030 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2014 | 14 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 2004 | 2469 | 0.030 |
Why?
|
| Papilloma | 1 | 1995 | 140 | 0.030 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2005 | 1642 | 0.030 |
Why?
|
| Hyperglycemia | 2 | 2019 | 1376 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2006 | 1964 | 0.030 |
Why?
|
| Metallothionein | 1 | 1994 | 61 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1994 | 221 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 1997 | 427 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2020 | 1444 | 0.030 |
Why?
|
| Melanoma | 1 | 2013 | 5709 | 0.030 |
Why?
|
| Blood | 1 | 1996 | 596 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 1998 | 665 | 0.030 |
Why?
|
| Keratins | 1 | 1995 | 498 | 0.030 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 1994 | 138 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1996 | 701 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2001 | 2206 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 1997 | 910 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 1994 | 197 | 0.030 |
Why?
|
| Dicumarol | 1 | 2013 | 9 | 0.030 |
Why?
|
| Phosphotyrosine | 1 | 1994 | 456 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2001 | 1336 | 0.030 |
Why?
|
| Genes, Viral | 2 | 1992 | 649 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2008 | 9318 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1995 | 1310 | 0.030 |
Why?
|
| Cell Death | 1 | 2018 | 1678 | 0.030 |
Why?
|
| Benzhydryl Compounds | 1 | 2000 | 916 | 0.030 |
Why?
|
| Retroviridae | 2 | 2005 | 850 | 0.030 |
Why?
|
| Osteopetrosis | 1 | 1992 | 43 | 0.030 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2018 | 1111 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1997 | 1416 | 0.030 |
Why?
|
| Gametogenesis | 1 | 1992 | 26 | 0.030 |
Why?
|
| B-Lymphocytes | 2 | 2004 | 4758 | 0.030 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1992 | 53 | 0.030 |
Why?
|
| Cinnamates | 1 | 1992 | 59 | 0.030 |
Why?
|
| Homozygote | 2 | 1998 | 1776 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 1994 | 728 | 0.030 |
Why?
|
| Glycerol | 1 | 1993 | 274 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 619 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 1994 | 393 | 0.030 |
Why?
|
| Cricetulus | 2 | 1989 | 814 | 0.030 |
Why?
|
| PC12 Cells | 1 | 1992 | 317 | 0.030 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2000 | 1606 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 2010 | 0.020 |
Why?
|
| Histamine | 1 | 1993 | 499 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2015 | 459 | 0.020 |
Why?
|
| Glycerol Kinase | 1 | 1991 | 17 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1992 | 531 | 0.020 |
Why?
|
| Chromatin | 1 | 2003 | 2960 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 1994 | 605 | 0.020 |
Why?
|
| Alprostadil | 1 | 1991 | 86 | 0.020 |
Why?
|
| Glycosylation | 1 | 1995 | 1098 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 1994 | 4544 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 1995 | 2016 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1996 | 1202 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1996 | 1510 | 0.020 |
Why?
|
| Chemotaxis | 2 | 1986 | 598 | 0.020 |
Why?
|
| Insulin Infusion Systems | 1 | 1993 | 217 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2012 | 269 | 0.020 |
Why?
|
| Sulfides | 1 | 2012 | 169 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 1995 | 773 | 0.020 |
Why?
|
| United States | 2 | 2024 | 72334 | 0.020 |
Why?
|
| NFI Transcription Factors | 1 | 1991 | 42 | 0.020 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 1991 | 41 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2021 | 2651 | 0.020 |
Why?
|
| Colorectal Neoplasms | 2 | 2002 | 6935 | 0.020 |
Why?
|
| Placenta | 1 | 2000 | 1709 | 0.020 |
Why?
|
| Eating | 1 | 1998 | 1539 | 0.020 |
Why?
|
| Forecasting | 1 | 2000 | 2928 | 0.020 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2013 | 259 | 0.020 |
Why?
|
| Point Mutation | 1 | 1996 | 1595 | 0.020 |
Why?
|
| Paralysis | 1 | 2012 | 250 | 0.020 |
Why?
|
| Ionomycin | 1 | 2010 | 110 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2003 | 2298 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 1998 | 1403 | 0.020 |
Why?
|
| Lymphopenia | 1 | 1992 | 281 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 1990 | 213 | 0.020 |
Why?
|
| Liver Neoplasms | 2 | 2003 | 4320 | 0.020 |
Why?
|
| Lymphocyte Activation | 2 | 1998 | 5486 | 0.020 |
Why?
|
| Ephedrine | 1 | 1990 | 52 | 0.020 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1989 | 73 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1995 | 2678 | 0.020 |
Why?
|
| Sex Factors | 1 | 2024 | 10552 | 0.020 |
Why?
|
| Kainic Acid | 1 | 2010 | 203 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 578 | 0.020 |
Why?
|
| Viral Proteins | 1 | 1997 | 1804 | 0.020 |
Why?
|
| Prostatic Neoplasms | 2 | 2004 | 11118 | 0.020 |
Why?
|
| Body Fluids | 1 | 2011 | 320 | 0.020 |
Why?
|
| Demecolcine | 2 | 1979 | 18 | 0.020 |
Why?
|
| Griseofulvin | 2 | 1979 | 10 | 0.020 |
Why?
|
| CHO Cells | 1 | 1992 | 1387 | 0.020 |
Why?
|
| Body Constitution | 1 | 2009 | 273 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 1989 | 455 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1993 | 2180 | 0.020 |
Why?
|
| Bezafibrate | 1 | 2008 | 14 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1971 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2449 | 0.020 |
Why?
|
| NF-kappa B | 1 | 1997 | 2490 | 0.020 |
Why?
|
| Uteroglobin | 1 | 2008 | 56 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 2496 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 1943 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 1990 | 192 | 0.020 |
Why?
|
| Fertility | 1 | 1993 | 771 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1996 | 1745 | 0.020 |
Why?
|
| Citrate (si)-Synthase | 1 | 2008 | 48 | 0.020 |
Why?
|
| Immunochemistry | 1 | 1988 | 116 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 1993 | 1059 | 0.020 |
Why?
|
| Chick Embryo | 1 | 1990 | 982 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2003 | 8181 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 15500 | 0.020 |
Why?
|
| Indoles | 2 | 2012 | 1833 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2021 | 3415 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2002 | 10090 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1990 | 783 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 1996 | 1436 | 0.020 |
Why?
|
| Photochemistry | 1 | 1988 | 239 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2008 | 5671 | 0.020 |
Why?
|
| Fos-Related Antigen-2 | 2 | 1997 | 14 | 0.020 |
Why?
|
| Glycogen | 1 | 2008 | 251 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2021 | 3979 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1988 | 257 | 0.020 |
Why?
|
| Biological Assay | 1 | 1990 | 626 | 0.020 |
Why?
|
| Rabbits | 2 | 1999 | 4772 | 0.020 |
Why?
|
| Immune Sera | 1 | 1987 | 606 | 0.020 |
Why?
|
| Thyroid Neoplasms | 1 | 2000 | 2332 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 1897 | 0.020 |
Why?
|
| Adrenalectomy | 1 | 1989 | 346 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1986 | 550 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2021 | 12341 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 733 | 0.020 |
Why?
|
| Proteomics | 1 | 2020 | 3849 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2011 | 1007 | 0.020 |
Why?
|
| Enzyme Induction | 2 | 1998 | 452 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2012 | 934 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2008 | 379 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 1999 | 3847 | 0.020 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1986 | 153 | 0.020 |
Why?
|
| Plasminogen Activators | 1 | 1986 | 199 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1987 | 510 | 0.020 |
Why?
|
| Polyomavirus | 1 | 1986 | 234 | 0.020 |
Why?
|
| Caffeine | 1 | 1990 | 700 | 0.020 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2005 | 25 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 1987 | 794 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1989 | 1386 | 0.020 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2005 | 158 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3810 | 0.020 |
Why?
|
| Osteocalcin | 1 | 2005 | 274 | 0.020 |
Why?
|
| Middle Aged | 9 | 2020 | 220895 | 0.010 |
Why?
|
| Learning | 1 | 1994 | 1740 | 0.010 |
Why?
|
| Memory | 1 | 1994 | 2188 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2010 | 1176 | 0.010 |
Why?
|
| Uncoupling Agents | 1 | 2004 | 46 | 0.010 |
Why?
|
| NFATC Transcription Factors | 2 | 1998 | 389 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 6485 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1996 | 2576 | 0.010 |
Why?
|
| Kidney | 2 | 1995 | 7048 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 1996 | 3188 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1986 | 1302 | 0.010 |
Why?
|
| Pyruvic Acid | 1 | 2005 | 204 | 0.010 |
Why?
|
| Diet | 2 | 2014 | 8075 | 0.010 |
Why?
|
| Glucose Intolerance | 1 | 2008 | 575 | 0.010 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 957 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2005 | 343 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2015 | 3065 | 0.010 |
Why?
|
| Mediator Complex | 1 | 2003 | 106 | 0.010 |
Why?
|
| Luciferases | 1 | 2005 | 714 | 0.010 |
Why?
|
| Running | 1 | 2008 | 488 | 0.010 |
Why?
|
| Denmark | 1 | 2005 | 771 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 2003 | 333 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2005 | 461 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2005 | 579 | 0.010 |
Why?
|
| Genotype | 3 | 2005 | 12990 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2008 | 865 | 0.010 |
Why?
|
| Caloric Restriction | 1 | 2005 | 299 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2003 | 621 | 0.010 |
Why?
|
| Echocardiography | 1 | 2015 | 4989 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 1998 | 4481 | 0.010 |
Why?
|
| Acetylation | 1 | 2005 | 1055 | 0.010 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 1860 | 0.010 |
Why?
|
| MyoD Protein | 1 | 2002 | 142 | 0.010 |
Why?
|
| Bucladesine | 1 | 1981 | 118 | 0.010 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2001 | 85 | 0.010 |
Why?
|
| Malate Dehydrogenase | 1 | 1981 | 40 | 0.010 |
Why?
|
| Vimentin | 1 | 1982 | 255 | 0.010 |
Why?
|
| Age Factors | 2 | 2015 | 18395 | 0.010 |
Why?
|
| Theophylline | 1 | 1981 | 131 | 0.010 |
Why?
|
| Peptide Biosynthesis | 1 | 1980 | 52 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2001 | 113 | 0.010 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 1980 | 51 | 0.010 |
Why?
|
| Epilepsy | 1 | 1996 | 3290 | 0.010 |
Why?
|
| Aged | 7 | 2015 | 169289 | 0.010 |
Why?
|
| Lysine | 1 | 2005 | 993 | 0.010 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2005 | 842 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2003 | 943 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2005 | 1998 | 0.010 |
Why?
|
| Swine | 3 | 1979 | 5915 | 0.010 |
Why?
|
| Peroxisome Proliferators | 1 | 1999 | 6 | 0.010 |
Why?
|
| Paired Box Transcription Factors | 1 | 2000 | 206 | 0.010 |
Why?
|
| Sebaceous Glands | 1 | 1999 | 42 | 0.010 |
Why?
|
| Adolescent | 2 | 2021 | 88319 | 0.010 |
Why?
|
| Linoleic Acids | 1 | 1999 | 39 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2005 | 1139 | 0.010 |
Why?
|
| Random Allocation | 1 | 2004 | 2395 | 0.010 |
Why?
|
| Macropodidae | 1 | 1979 | 11 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1999 | 227 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1980 | 411 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1999 | 136 | 0.010 |
Why?
|
| Base Pairing | 1 | 1999 | 140 | 0.010 |
Why?
|
| Zebrafish Proteins | 1 | 2005 | 1014 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1999 | 365 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1987 | 4615 | 0.010 |
Why?
|
| Phenylethanolamine N-Methyltransferase | 1 | 1998 | 18 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 1983 | 1170 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 1998 | 97 | 0.010 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 1999 | 224 | 0.010 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 1998 | 56 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 6310 | 0.010 |
Why?
|
| Culture Media | 1 | 1980 | 897 | 0.010 |
Why?
|
| Pregnancy | 1 | 2000 | 29874 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2005 | 3606 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1999 | 698 | 0.010 |
Why?
|
| Cell Movement | 1 | 1990 | 5203 | 0.010 |
Why?
|
| Molecular Probes | 1 | 1999 | 309 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1998 | 304 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 2001 | 642 | 0.010 |
Why?
|
| Dimerization | 1 | 1999 | 891 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1999 | 405 | 0.010 |
Why?
|
| Vinblastine | 1 | 1979 | 488 | 0.010 |
Why?
|
| Adrenergic beta-1 Receptor Agonists | 1 | 1997 | 14 | 0.010 |
Why?
|
| Longevity | 1 | 2005 | 1065 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1999 | 569 | 0.010 |
Why?
|
| Simvastatin | 1 | 1999 | 346 | 0.010 |
Why?
|
| Aurothioglucose | 1 | 1996 | 11 | 0.010 |
Why?
|
| Dobutamine | 1 | 1997 | 116 | 0.010 |
Why?
|
| Intermediate Filament Proteins | 1 | 1997 | 262 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 4111 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2005 | 1615 | 0.010 |
Why?
|
| Suppression, Genetic | 1 | 1996 | 190 | 0.010 |
Why?
|
| Prostatectomy | 1 | 2004 | 1824 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2002 | 2645 | 0.010 |
Why?
|
| Restraint, Physical | 1 | 1998 | 187 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1979 | 960 | 0.010 |
Why?
|
| Maleimides | 1 | 1996 | 113 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1998 | 778 | 0.010 |
Why?
|
| Genes, Immediate-Early | 1 | 1996 | 102 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2000 | 582 | 0.010 |
Why?
|
| Disease Progression | 2 | 2003 | 13506 | 0.010 |
Why?
|
| Lipolysis | 1 | 1997 | 212 | 0.010 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1996 | 180 | 0.010 |
Why?
|
| Catechols | 1 | 1975 | 62 | 0.010 |
Why?
|
| Collagen | 1 | 1983 | 2638 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1998 | 552 | 0.010 |
Why?
|
| Dentate Gyrus | 1 | 1996 | 164 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2003 | 4021 | 0.010 |
Why?
|
| Carcinoma, Papillary | 1 | 2000 | 785 | 0.010 |
Why?
|
| Gene Dosage | 1 | 1999 | 1217 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2003 | 3595 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1999 | 1062 | 0.010 |
Why?
|
| Prostaglandins | 1 | 1995 | 398 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2000 | 1393 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 2001 | 883 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 12725 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1994 | 148 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1994 | 317 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1996 | 1262 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1997 | 1132 | 0.010 |
Why?
|
| Tryptophan | 1 | 1975 | 482 | 0.010 |
Why?
|
| Hygromycin B | 1 | 1992 | 11 | 0.010 |
Why?
|
| Kanamycin Kinase | 1 | 1992 | 34 | 0.010 |
Why?
|
| Ovary | 1 | 1977 | 959 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2004 | 64680 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1996 | 1232 | 0.010 |
Why?
|
| Propranolol | 1 | 1994 | 489 | 0.010 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 1996 | 1039 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2005 | 3537 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1994 | 899 | 0.010 |
Why?
|
| Visual Pathways | 1 | 1996 | 551 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 1992 | 303 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1993 | 445 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1979 | 1250 | 0.010 |
Why?
|
| Baculoviridae | 1 | 1990 | 115 | 0.010 |
Why?
|
| Sympathomimetics | 1 | 1990 | 56 | 0.010 |
Why?
|
| Secretory Rate | 1 | 1989 | 81 | 0.010 |
Why?
|
| Spleen | 1 | 1996 | 2295 | 0.010 |
Why?
|
| Light | 1 | 1996 | 1353 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 1990 | 224 | 0.010 |
Why?
|
| Adenoma | 1 | 2000 | 2160 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1992 | 825 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1989 | 384 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 20570 | 0.000 |
Why?
|
| Intracellular Membranes | 1 | 1989 | 389 | 0.000 |
Why?
|
| Axons | 1 | 1996 | 1674 | 0.000 |
Why?
|
| Solubility | 1 | 1989 | 1091 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 2004 | 58976 | 0.000 |
Why?
|
| Biopsy | 1 | 1999 | 6766 | 0.000 |
Why?
|
| Embryo, Mammalian | 1 | 1992 | 1675 | 0.000 |
Why?
|
| Risk Factors | 1 | 2014 | 74206 | 0.000 |
Why?
|
| Psychomotor Performance | 1 | 1994 | 1881 | 0.000 |
Why?
|
| Sex Characteristics | 1 | 1995 | 2639 | 0.000 |
Why?
|
| Retina | 1 | 1996 | 2659 | 0.000 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 1999 | 3245 | 0.000 |
Why?
|
| Immunoassay | 1 | 1988 | 745 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1990 | 2048 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1988 | 2469 | 0.000 |
Why?
|
| Seizures | 1 | 1996 | 2957 | 0.000 |
Why?
|
| Transduction, Genetic | 1 | 1986 | 903 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 36426 | 0.000 |
Why?
|
| Chickens | 1 | 1979 | 859 | 0.000 |
Why?
|
| Species Specificity | 1 | 1979 | 2414 | 0.000 |
Why?
|
| Child | 1 | 2000 | 80153 | 0.000 |
Why?
|